表紙:AI医療診断の世界市場規模:ソリューション、技術、用途、エンドユーザー、地域別、動向分析、市場競合シナリオおよび展望(2020年~2026年)
市場調査レポート
商品コード
954899

AI医療診断の世界市場規模:ソリューション、技術、用途、エンドユーザー、地域別、動向分析、市場競合シナリオおよび展望(2020年~2026年)

Global Artificial Intelligence Diagnostic Market Size, By Solution, By Technology, By Application, By End User, By Region, Trend Analysis, Market Competition Scenario & Outlook, 2020-2026.

出版日: | 発行: Blueweave Consulting & Research Private Limited | ページ情報: 英文 161 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.86円
AI医療診断の世界市場規模:ソリューション、技術、用途、エンドユーザー、地域別、動向分析、市場競合シナリオおよび展望(2020年~2026年)
出版日: 2020年07月01日
発行: Blueweave Consulting & Research Private Limited
ページ情報: 英文 161 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界のAI医療診断市場は、2019年に2億8,810万米ドルとなりました。同市場は、2020年から2027年の予測期間中に32.3%のCAGRで成長する見通しで、2027年には20億4,391万米ドルに達すると予測されています。診断コストと機器のダウンタイムの削減、患者の治療を改善するための高まる要件は、医療診断におけるAIの受け入れを推進しています。さらに、低コストの診断方法への要求の高まり、実際の有能なレポートテスト、迅速な診断データの生成などが、同市場の成長を推進する要因となっています。また、多数のAIソリューションプロバイダーや医療施設間の戦略的提携・協業の増加が同市場の発展にプラスの影響を与えています。

当レポートは、世界のAI医療診断市場について調査しており、市場の成長および抑制要因、機会、課題、シェア、ソリューション・技術・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査の枠組み

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の市場分析

  • 業界のバリューチェーン分析
  • DROC分析
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • 技術情勢
  • 規制の枠組み
  • 企業の市場シェア分析(2019)
  • ポーターのファイブフォース分析
  • 戦略的展望

第5章 世界の人工知能診断市場概要

  • 市場推計・売上別予測(2016-2026)
    • 売上別
  • 市場シェアと予測
    • ソリューション別
      • ハードウェア
      • ソフトウェア
      • その他
    • 技術別
      • 音声認識
      • クエリ方法
      • 自然言語処理
      • 機械学習
      • コンテキスト認識処理
    • 用途別
      • イメージング・診断
      • 創薬
      • ライフスタイル管理・モニタリング
      • 緊急治療室・病院管理
      • インサイト・リスク分析
      • ウェアラブル
      • 仮想アシスタント
      • その他
    • エンドユーザー別
      • 病院
      • 製薬企業
      • 診断センター
      • クリニック
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • 南米
      • 中東・アフリカ

第6章 北米

第7章 欧州

第8章 アジア太平洋

第9章 南米

第10章 中東およびアフリカ

第11章 企業プロファイル (企業概要、財務マトリックス、製品情勢、主要人材、主要競合他社、連絡先住所、および戦略的展望)

  • IBM Corporation
  • Google, Inc.
  • NVIDIA Corporation
  • Microsoft Corporation
  • ICarbonX
  • Next IT Corp.
  • CloudMex Inc.
  • Carescore
  • Atomwise Inc.
  • Zephyr Health Inc.
  • Deep Genomics Inc.
  • Medtronic Plc.
  • Koninkiljke Philips N.V.
  • Oncora Medical, Inc.

第12章 戦略的提言

目次
Product Code: BWC20108

Title:
Global Artificial Intelligence Diagnostic Market Size, By Solution (Hardware and Software & Services), By Technology (Speech Recognition, Querying Method, Natural Language Processing, Machine Learning, and Context-Aware Processing), By Application (Imaging & Diagnostics, Drug Discovery, Lifestyle Management & Monitoring, Emergency Room & Hospital Management, Insights & Risk Analytics, Wearables, Virtual Assistants, and Others), By End User (Hospitals, Pharmaceutical Organizations, Diagnostic Centers, and Clinics), By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa), Trend Analysis, Market Competition Scenario & Outlook, 2020-2026..

The Global AI Diagnostic market to witness massive growth at Exceptional CAGR of 32.3% increasing its valuation 7X by 2027

According to BlueWeave Consulting, the Global Artificial Intelligence Diagnostic Market is anticipated to reach USD 2043.91 million by 2027 from USD 288.1 million in 2019, at a CAGR of 32.3% during the forecast period 2020-2027. Growing requirement for reducing diagnostic costs and machine down time and improving patient care, drive the acceptance and application of artificial intelligence in healthcare diagnostics. Besides, growing requests for low-cost diagnostic methods, actual and competent report testing and quick diagnostic data generation are some of the other factors propel the market for AI in diagnostics.

Artificial intelligence (AI) is used in healthcare to approximate human perception and derive findings of complicated medical and diagnostic imaging data. It plays a critical role in determining the relationship between treatment techniques and patient outcomes in healthcare. AI programs are deployed in multiple medical implications such as diagnostic procedures, drug growth, personalized medicines, and patient testing care. AI cloud is useful in clinical procedures to check the vital signs, probing questions, and giving patients prescriptions. AI systems can also be used for warnings and reminders, image interpretation, information retrieval, and treatment plan during medical procedures.

Deep learning technology of AI is used extensively for image acknowledgement, signal recognition, and data removal. AI can discern more useful patterns than human eyes. It paves the way for the emergence of a new age medical diagnostic devices proficient in surpassing diagnosis skills of the best doctors. As neural networks in artificial intelligence can imagine, a significant number of patients can avail the advantage of its proficiency. Moreover, increasing strategic partnerships and collaborations among numerous AI solution providers and health facilities positively influences market development.

"The software segment plays a vital role in the Artificial Intelligence Diagnostics Market."

Software segment in the AI healthcare market is expected to witness the highest CAGR during the forecast period. Many companies are engaged in developing new software solutions for various emerging healthcare applications; this is a critical factor adding to the development of the software segment. The growing acceptance of AI-driven healthcare informatics solutions and healthcare operational support by hospitals and other healthcare service providers is projected to grow the demand for AI diagnostics in the latter part of the projection period.

"Medical Imaging & Diagnostics Section dominates AI Healthcare Market."

Medical imaging & diagnostics section dominates the AI healthcare market and is anticipated to grow at the highest CAGR during the forecast period. The substantial development of the medical imaging and diagnostics segment is attributed to the factors such as the existence of a large volume of imaging data, high ROI offered by AI systems to radiologists in analysis and cure management, and the influx of a large number of startups in this section.

"The key drivers of AI Diagnostic Market are alliances between AI solutions providers & health facilities, and the growth of advanced AI technologies."

Growing strategic partnerships and collaborations between numerous AI solution providers and healthcare facilities help in taking forward leaps and in progressing exponentially. The alliances improve operational and diagnostic efficiencies, benefitting patients. For example, Boston based Partners HealthCare collaborated with FUJIFILM SonoSite, Inc. in August 2019 for deploying AI in transferrable ultrasound technology, valuable for point-of-care testing. Under this partnership, FUJIFILM uses the clinical expertise, datasets, and IT setup of Partners HealthCare with its portable ultrasound technology for developing AI-powered ultrasound devices. Such devices are extensively and aptly used in emergency medical procedures, reducing the time-delay between trauma and diagnosis, making fast interferences and improved patient recovery.

The major factors accelerating the development of the Global Artificial Intelligence (AI) market include the rise in the acceptance of cloud-based applications and services and the growth of big data applications across the globe. The elaborated integration of image acknowledgement technology with optical character recognition, pattern matching, and face recognition in various end-use applications such as drones, self-driving cars, and robotics will push the development of the artificial intelligence market during the forthcoming period. Such developments increase the potential of AI applications in healthcare.

"The Asia Pacific is anticipated to register vital growth in the market during the projection period."

The Asia Pacific is expected to be the most profitable market growing at an unprecedented rate during the forecast period. Governments in this region, have allocated substantial outlay for the healthcare sector and have taken initiatives for the adoption of AI-based diagnostic technologies by healthcare practitioners and other healthcare organizations. AI applications lead to increased savings to healthcare entities, better information exchange and improved clinical outcomes.

China allocates massive outlay for the healthcare sector of the country with special plans for AI adoption, among APAC countries and has delineated official layouts to digitize medical records. Japan is likely to emerge as the second-largest market share during the prediction period. These factors, combined with cost-efficiencies, are anticipated to drive the development of the market for AI in diagnostics in the Asia Pacific during the upcoming period.

The leading companies in this market are IBM Corporation, Google, Inc., NVIDIA Corporation, Microsoft Corporation, iCarbonX, Next IT Corp., CloudMex Inc., Carescore, Atomwise Inc., Zephyr Health Inc., Deep Genomics Inc., Medtronic Plc., Koninkiljke Philips N.V., and Oncora Medical, Inc. and others.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Research Methodology

  • 2.1. Qualitative Research
    • 2.1.1. Primary & Secondary Sources
  • 2.2. Quantitative Research
    • 2.2.1. Primary & Secondary Sources
  • 2.3. Market Breakdown & Data Triangulation
    • 2.3.1. Secondary Research
    • 2.3.2. Primary Research
  • 2.4. Regional Classification of Primary Research Respondents
  • 2.5. Assumptions & Limitations

3. Executive Summary

4. Global Artificial Intelligence Diagnostics Market Insights

  • 4.1. Industry Value Chain Analysis
  • 4.2. DROC Analysis
    • 4.2.1. Growth Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
    • 4.2.4. Challenges
  • 4.3. Technological Landscape
  • 4.4. Regulatory Framework
  • 4.5. Company Market Share Analysis,2019
  • 4.6. Porter's Five forces analysis
    • 4.6.1. Bargaining Power of Suppliers
    • 4.6.2. Bargaining Power of Buyers
    • 4.6.3. Threat of New Entrants
    • 4.6.4. Threat of Substitutes
    • 4.6.5. Intensity of Rivalry
  • 4.7. Strategic Outlook

5. Global Artificial Intelligence Diagnostics Market Overview

  • 5.1. Market Estimates & Forecast By Value, 2016-2026
    • 5.1.1. By Value (USD)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Solution
      • 5.2.1.1. Hardware
      • 5.2.1.2. Software
      • 5.2.1.3. Others
    • 5.2.2. By Technology
      • 5.2.2.1. Speech Recognition
      • 5.2.2.2. Querying Method
      • 5.2.2.3. Natural Language Processing
      • 5.2.2.4. Machine Learning
      • 5.2.2.5. Context Aware Processing
    • 5.2.3. By Application
      • 5.2.3.1. Imaging & Diagnostics
      • 5.2.3.2. Drug Discovery
      • 5.2.3.3. Lifestyle Management & Monitoring
      • 5.2.3.4. Emergency Room & Hospital Management
      • 5.2.3.5. Insights & Risk Analytics
      • 5.2.3.6. Wearables
      • 5.2.3.7. Virtual Assistants
      • 5.2.3.8. Others
    • 5.2.4. By End User
      • 5.2.4.1. Hospitals
      • 5.2.4.2. Pharmaceutical Organizations
      • 5.2.4.3. Diagnostics centers
      • 5.2.4.4. Clinics
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia Pacific
      • 5.2.5.4. South America
      • 5.2.5.5. Middle East & Africa

6. North America Artificial Intelligence Diagnostics Market

  • 6.1. Market Estimates & Forecast By Value, 2016-2026
    • 6.1.1. By Value (USD)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Solution
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
      • 6.2.5.1. U.S
      • 6.2.5.2. Canada

7. Europe Artificial Intelligence Diagnostics Market

  • 7.1. Market Estimates & Forecast By Value, 2016-2026
    • 7.1.1. By Value (USD)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Solution
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
      • 7.2.5.1. Germany
      • 7.2.5.2. U.K
      • 7.2.5.3. France
      • 7.2.5.4. Italy
      • 7.2.5.5. Rest of Europe

8. Asia Pacific Artificial Intelligence Diagnostics Market

  • 8.1. Market Estimates & Forecast By Value, 2016-2026
    • 8.1.1. By Value (USD)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Solution
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
      • 8.2.5.1. China
      • 8.2.5.2. India
      • 8.2.5.3. Japan
      • 8.2.5.4. South Korea
      • 8.2.5.5. Rest of APAC

9. South America Artificial Intelligence Diagnostics Market

  • 9.1. Market Estimates & Forecast By Value, 2016-2026
    • 9.1.1. By Value (USD)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Solution
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
      • 9.2.5.1. Brazil
      • 9.2.5.2. Mexico
      • 9.2.5.3. Argentina
      • 9.2.5.4. Rest of Latin America

10. Middle East & Africa Artificial Intelligence Diagnostics Market

  • 10.1. Market Estimates & Forecast By Value, 2016-2026
    • 10.1.1. By Value (USD)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Solution
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
      • 10.2.5.1. Saudi Arabia
      • 10.2.5.2. UAE
      • 10.2.5.3. South Africa
      • 10.2.5.4. Rest of MEA

11. Company Profile (Company Overview, Financial Matrix, Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)*

  • *IBM Corporation
  • *Google, Inc.
  • *NVIDIA Corporation
  • *Microsoft Corporation
  • *ICarbonX
  • *Next IT Corp.
  • *CloudMex Inc.
  • *Carescore
  • *Atomwise Inc.
  • *Zephyr Health Inc.
  • *Deep Genomics Inc.
  • *Medtronic Plc.
  • *Koninkiljke Philips N.V.
  • *Oncora Medical, Inc.

12. Strategic Recommendation